Abstract
Background/Objectives:
It has been shown that plasma carnitine concentrations markedly decline during gestation in women. The reason for this, however, is unknown. One objective of this study was to investigate the effect of carnitine supplementation on plasma carnitine concentrations in pregnant women. The second objective was to investigate the hypothesis that reduced plasma carnitine concentrations during gestation are caused by a reduced carnitine synthesis because of a diminished iron status.
Subjects/Methods:
Healthy pregnant women (n=26) were randomly assigned in two groups receiving either a L-carnitine supplement (500 mg L-carnitine per day as L-carnitine L-tartrate) (n=13) or placebo (n=13) from the 13th week of gestation to term.
Results:
In the control group, there was a marked reduction of plasma carnitine concentration from the 12th week of gestation to term. This reduction was prevented by the supplementation of carnitine. In the control group, there was a positive relationship between the parameters of iron status (mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH) and ferritin) and plasma concentration of carnitine (P<0.05). Moreover, there were inverse correlations between the concentrations of ferritin and the carnitine precursor γ-butyrobetaine in plasma, and between γ-butyrobetaine and carnitine in plasma (P<0.05).
Conclusions:
This study confirms that plasma carnitine concentrations decline in the course of pregnancy, an effect that can be prevented by the supplementation of carnitine. Data of this study, moreover, suggest that the decline of plasma carnitine concentration during pregnancy could be caused by a reduced rate of carnitine biosynthesis, possibly because of an inadequate iron status.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Bargen-Lockner C, Hahn P, Wittmann B (1981). Plasma carnitine in pregnancy. Am J Obestet Gynecol 140, 412–414.
Bartholmey SJ, Sherman AR (1985). Carnitine levels in iron-deficient rat pups. J Nutr 115, 138–145.
Bartholmey SJ, Sherman AR (1986). Impaired ketogenesis in iron-deficient rat pups. J Nutr 116, 2180–2189.
Böhles H, Evangeliov A, Bervoets K, Eckert I, Sewell AC (1994). Carnitine esters in metabolic disease. Eur J Pediatr 153, S57–S61.
Böhles H, Ullrich K, Endres W, Behbehani AW, Wendel U (1991). Inadequate iron availability as a possible cause of low serum carnitine concentrations in patients with phenylketonuria. Eur J Pediatr 150, 425–428.
Cederblad G, Fåhraeus L, Lindgren K (1986). Plasma carnitine and renal-carnitine clearance during pregnancy. Am J Clin Nutr 44, 379–383.
Cederblad G, Niklasson A, Rydgren B, Albertsson-Wikland A, Olegård R (1985). Carnitine in maternal and neonatal plasma. Acta Pediatr Scand 74, 500–504.
Cemeroglu AP, Kocaba° CN, Co°kun T, Gürgey A (2001). Low serum carnitine concentrations in healthy children with iron deficiency anemia. Pediatr Hematol Oncol 18, 491–495.
Cho SW, Park YO, Cha YS (2003). Plasma and urinary concentration in pregnant Korean women. FASEB 17, A733–A734.
Citak EC, Citak FE, Kurekci AE (2006). Serum carnitine levels in children with iron- deficiency anemia with or without pica. Pediatr Hematol Oncol 23, 381–385.
Duran M, Loof NE, Ketting D, Dorland L (1990). Secondary carnitine deficiency. J Clin Chem Clin Biochem 28, 359–363.
Genger H, Sevelda P, Vytiska-Binstorfer E, Salzer H, Legenstein E, Lohninger A (1988). Carnitine levels in pregnancy. Z Geburtshilfe Perinatol 192, 134–136.
Grube M, Schwabedissen HM, Draber K, Präger D, Möritz KU, Linnemann K et al. (2005). Expression, localization, and function of the carnitine transporter octn2 (slc22a5) in human placenta. Drug Metab Dispos 33, 31–37.
Günter HH, Peulecke W, Oehler K, Scharf A, Schumann G, Sohn C (2002). The concentration of carnitine in the last trimester of pregnancy subject to glucose tolerance. Zentralbl Gynakol 124, 533–537.
Hahn P (1982). Development of lipid metabolism. Annu Rev Nutr 2, 91–111.
Harvey LJ, Dainty JR, Hollands WJ, Bull VJ, Hoogewerff JA, Foxall RJ et al. (2007). Effect of high-dose iron supplements on fractional zinc absorption and status in pregnant women. Am J Clin Nutr 85, 131–136.
Lain KY, Catalano PM (2007). Metabolic changes in pregnancy. Clin Obstet Gynecol 50, 938–948.
Lindstedt G, Lindstedt S (1970). Cofactor requirements of γ-butyrobetaine hydroxylase from rat liver. J Biol Chem 245, 4178–4186.
Marzo A, Cardace G, Corbelletta C, Pace S, D'Iddio S, Verrotti C et al. (1994). Plasma concentration, urinary excretion and renal clearance of L-carnitine during pregnancy: a reversible secondary L-carnitine deficiency. Gynecol Endocrinol 8, 115–120.
McGarry JD, Brown NF (1997). The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 244, 1–14.
Milman N (2006). Iron and pregnancy—a delicate balance. Ann Hematol 85, 559–565.
Mitchell ME, Snyder EA (1991). Dietary carnitine effects on carnitine concentrations in urine and milk in lactating women. Am J Clin Nutr 54, 814–820.
Novak M, Monkus EF, Chung D, Buch M (1981). Carnitine in the perinatal metabolism of lipids. I. Relationship between maternal and fetal plasma levels of carnitine and acylcarnitines. Pediatrica 67, 95–100.
Novak M, Penn-Walker D, Hahn P, Monkus EF (1975a). Effect of carnitine on lipolysis in subcutaneous adipose tissue of newborns. Biol Neonate 25, 84–94.
Novak M, Penn-Walker D, Monkus EF (1975b). Oxidation of fatty acids by mitochondria obtained from newborn subcutaneous (white) adipose tissue. Biol Neonate 25, 95–107.
Rebouche CJ, Bosch EP, Chenard CA, Schabold KJ, Nelson SE (1989). Utilization of dietary precursors for carnitine synthesis in human adults. J Nutr 119, 1907–1913.
Rebouche CJ, Seim H (1998). Carnitine metabolism and its regulation in microorganisms and mammals. Annu Rev Nutr 18, 39–61.
Ringseis R, Pösel S, Hirche F, Eder K (2007). Treatment with pharmacological peroxisome proliferator-activated receptor alpha agonist clofibrate causes upregulation of organic cation transporter 2 in liver and small intestine of rats. Pharmacol Res 56, 175–183.
Schmidt-Sommerfeld E, Penn D, Sodha RJ, Prögler M, Novak M, Schneider H (1985). Transfer and metabolism of carnitine and carnitine esters in the in vitro perfused human placenta. Pediatr Res 19, 700–706.
Schoderbeck M, Auer B, Legenstein E, Genger H, Sevelda P, Salzer H et al. (1995). Pregnancy-related changes of carnitine and acylcarnitine concentrations of plasma and erythrocytes. J Perinat Med 23, 477–485.
Spiering BA, Kraemer WJ, Vingren JL, Hatfield DL, Fragala MS, Ho JY et al. (2007). Responses of criterion variables to different supplemental doses of L-carnitine L-tartrate. J Strength Cond Res 21, 259–264.
Steiber A, Kerner J, Hoppel CL (2004). Carnitine: a nutritional, biosynthetic, and functional perspective. Mol Asp Med 25, 455–473.
Tanzer F, Hizel S, Cetinkaya O, Sekreter E (2001). Serum free carnitine and total triglyceride levels in children with iron deficiency anemia. Int J Vitam Nutr Res 71, 66–69.
Vaz FM, Wanders RJ (2002). Carnitine biosynthesis in mammals. Biochem J 361, 417–429.
Vaz FM, Ofman R, Westinga K, Wanders RJ (2001). Molecular and biochemical characterization of rat ɛ-N-trimethyllysine hydroxylase, the first enzyme of carnitine biosynthesis. J Biol Chem 276, 33512–33517.
Volek JS, Kraemer WJ, Rubin MR, Gómez AL, Ratamess NA, Gaynor P (2002). L-Carnitine L-tartrate supplementation favorably affects markers of recovery from exercise stress. Am J Physiol Endocrinol Metab 282, E474–E482.
Warshaw JB, Curry E (1980). Comparison of serum carnitine and ketone body concentrations in breast- and in formula-fed newborn infants. J Pediatr 97, 122–125.
Acknowledgements
This study was in part supported by Lonza (Basel, Switzerland). We thank all the women who took part in the study, the midwives and medical practitioners of the Department of Obstetrics and Gynecology; Ewald Seliger and members of hormone laboratory of the University Hospital. We also thank Frank Hirche for measuring the carnitine compounds with HPLC-MS/MS.
Author information
Authors and Affiliations
Corresponding author
Additional information
Contributors: UK and KE designed the study concept and GS and FR provided significant advice on this concept. CW, GS and CS were responsible for the study coordination, proband care and the sample collection. UK was responsible for the analyses. UK and KE led the writing. All authors read and approved the final version of the manuscript.
Rights and permissions
About this article
Cite this article
Keller, U., van der Wal, C., Seliger, G. et al. Carnitine status of pregnant women: effect of carnitine supplementation and correlation between iron status and plasma carnitine concentration. Eur J Clin Nutr 63, 1098–1105 (2009). https://doi.org/10.1038/ejcn.2009.36
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejcn.2009.36
Keywords
This article is cited by
-
Serum betaine and dimethylglycine in mid-pregnancy and the risk of gestational diabetes mellitus: a case-control study
Endocrine (2024)
-
Pregnancy in GNE myopathy patients: a nationwide repository survey in Japan
Orphanet Journal of Rare Diseases (2020)
-
Maternal urinary metabolic signatures of fetal growth and associated clinical and environmental factors in the INMA study
BMC Medicine (2016)
-
Low availability of carnitine precursors as a possible reason for the diminished plasma carnitine concentrations in pregnant women
BMC Pregnancy and Childbirth (2010)